00719.HK
Shandong Xinhua Pharmaceutical Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 5.35
−1.11%Year over year
Reported trailing growth
- Revenue
- -5.6%
- EBITDA
- -43.7%
- EBIT
- -37.1%
- EPS
- -37.7%
- Free cash flow
- +11.4%
- Operating cash flow
- +18.3%
Forward estimates
Based on analyst estimates
- Revenue
- -3.6%
- EBITDA
- +206.4%
- EPS
- +187.8%
Three-year CAGR
- Revenue
- +5.3%
- EBITDA
- -0.7%
- EBIT
- -8.6%
- Net income
- -11.0%
- EPS
- -12.2%
- Free cash flow
- -6.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026